• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宿主遗传学和肠道微生物群及代谢组学在炎症性肠病发病机制中的新作用。

The Role of Host Genetics and Intestinal Microbiota and Metabolome as a New Insight into IBD Pathogenesis.

机构信息

Institute of Human Genetics, Polish Academy of Sciences, 60-479 Poznan, Poland.

Department of Gastroenterology, Dietetics and Internal Medicine, Poznan University of Medical Sciences, 60-355 Poznan, Poland.

出版信息

Int J Mol Sci. 2024 Sep 4;25(17):9589. doi: 10.3390/ijms25179589.

DOI:10.3390/ijms25179589
PMID:39273536
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11394875/
Abstract

Inflammatory bowel disease (IBD) is an incurable, chronic disorder of the gastrointestinal tract whose incidence increases every year. Scientific research constantly delivers new information about the disease and its multivariate, complex etiology. Nevertheless, full discovery and understanding of the complete mechanism of IBD pathogenesis still pose a significant challenge to today's science. Recent studies have unanimously confirmed the association of gut microbial dysbiosis with IBD and its contribution to the regulation of the inflammatory process. It transpires that the altered composition of pathogenic and commensal bacteria is not only characteristic of disturbed intestinal homeostasis in IBD, but also of viruses, parasites, and fungi, which are active in the intestine. The crucial function of the microbial metabolome in the human body is altered, which causes a wide range of effects on the host, thus providing a basis for the disease. On the other hand, human genomic and functional research has revealed more loci that play an essential role in gut homeostasis regulation, the immune response, and intestinal epithelial function. This review aims to organize and summarize the currently available knowledge concerning the role and interaction of crucial factors associated with IBD pathogenesis, notably, host genetic composition, intestinal microbiota and metabolome, and immune regulation.

摘要

炎症性肠病(IBD)是一种不可治愈的慢性胃肠道疾病,其发病率逐年增加。科学研究不断提供有关该疾病及其多因素、复杂病因的新信息。然而,要完全发现和理解 IBD 发病机制的完整机制,仍然是当今科学面临的重大挑战。最近的研究一致证实了肠道微生物失调与 IBD 的关联及其对炎症过程的调节作用。事实证明,致病性和共生细菌组成的改变不仅是 IBD 中肠道内稳态紊乱的特征,也是病毒、寄生虫和真菌在肠道中活跃的特征。微生物代谢组在人体中的关键功能发生改变,从而对宿主产生广泛的影响,为疾病提供了基础。另一方面,人类基因组和功能研究揭示了更多在肠道内稳态调节、免疫反应和肠道上皮功能中起重要作用的基因座。本综述旨在组织和总结与 IBD 发病机制相关的关键因素的作用和相互作用的现有知识,特别是宿主遗传组成、肠道微生物群和代谢组以及免疫调节。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9592/11394875/9454d249398e/ijms-25-09589-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9592/11394875/182e554b1e48/ijms-25-09589-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9592/11394875/9454d249398e/ijms-25-09589-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9592/11394875/182e554b1e48/ijms-25-09589-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9592/11394875/9454d249398e/ijms-25-09589-g002.jpg

相似文献

1
The Role of Host Genetics and Intestinal Microbiota and Metabolome as a New Insight into IBD Pathogenesis.宿主遗传学和肠道微生物群及代谢组学在炎症性肠病发病机制中的新作用。
Int J Mol Sci. 2024 Sep 4;25(17):9589. doi: 10.3390/ijms25179589.
2
Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches.肠道细菌、病毒和真菌在炎症性肠病发病机制中的作用及治疗方法
Gastroenterology. 2017 Feb;152(2):327-339.e4. doi: 10.1053/j.gastro.2016.10.012. Epub 2016 Oct 18.
3
Microbiota as Therapeutic Targets.微生物群作为治疗靶点
Dig Dis. 2016;34(5):558-65. doi: 10.1159/000445263. Epub 2016 Jun 22.
4
Fecal Microbiota and Metabolome in a Mouse Model of Spontaneous Chronic Colitis: Relevance to Human Inflammatory Bowel Disease.自发性慢性结肠炎小鼠模型中的粪便微生物群和代谢组:与人类炎症性肠病的相关性
Inflamm Bowel Dis. 2016 Dec;22(12):2767-2787. doi: 10.1097/MIB.0000000000000970.
5
A comprehensive guide to assess gut mycobiome and its role in pathogenesis and treatment of inflammatory bowel disease.评估肠道真菌微生物群及其在炎症性肠病发病机制和治疗中作用的综合指南。
Indian J Gastroenterol. 2024 Feb;43(1):112-128. doi: 10.1007/s12664-023-01510-0. Epub 2024 Feb 27.
6
Gut microbiota in the pathogenesis of inflammatory bowel disease.肠道微生物群在炎症性肠病发病机制中的作用
Clin J Gastroenterol. 2018 Feb;11(1):1-10. doi: 10.1007/s12328-017-0813-5. Epub 2017 Dec 29.
7
Gut microbiome, metabolome, host immunity associated with inflammatory bowel disease and intervention of fecal microbiota transplantation.肠道微生物组、代谢组、宿主免疫与炎症性肠病的关系及粪便微生物移植的干预作用。
J Autoimmun. 2023 Dec;141:103062. doi: 10.1016/j.jaut.2023.103062. Epub 2023 May 27.
8
Microbiome and metabolome in inflammatory bowel disease.炎症性肠病中的微生物组和代谢组学。
J Gastroenterol Hepatol. 2023 Jan;38(1):34-43. doi: 10.1111/jgh.16043. Epub 2022 Nov 6.
9
[Insights into the Pathogenesis of Inflammatory Bowel Diseases: Genetics and Microbiota].炎症性肠病的发病机制洞察:遗传学与微生物群
Ther Umsch. 2019 Jan;75(5):273-279. doi: 10.1024/0040-5930/a000999.
10
Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.炎症性肠病和结直肠癌中的微生物群变化:结肠细胞反应的改变
World J Gastroenterol. 2014 Dec 28;20(48):18121-30. doi: 10.3748/wjg.v20.i48.18121.

引用本文的文献

1
New potential biomarkers of ulcerative colitis and disease course - integrated metagenomic and metabolomic analysis among Polish patients.溃疡性结肠炎及疾病进程的新潜在生物标志物——波兰患者的宏基因组与代谢组学综合分析
J Gastroenterol. 2025 Jul 4. doi: 10.1007/s00535-025-02280-6.

本文引用的文献

1
Endoplasmic reticulum stress is upregulated in inflammatory bowel disease and contributed TLR2 pathway-mediated inflammatory response.内质网应激在炎症性肠病中上调,并促进 TLR2 通路介导的炎症反应。
Immunopharmacol Immunotoxicol. 2024 Apr;46(2):192-198. doi: 10.1080/08923973.2023.2298897. Epub 2024 Jan 4.
2
Intermediate role of gut microbiota in vitamin B nutrition and its influences on human health.肠道微生物群在维生素B营养中的中间作用及其对人类健康的影响。
Front Nutr. 2022 Dec 13;9:1031502. doi: 10.3389/fnut.2022.1031502. eCollection 2022.
3
Where Do We Stand in the Behavioral Pathogenesis of Inflammatory Bowel Disease? The Western Dietary Pattern and Microbiota-A Narrative Review.
炎症性肠病的行为发病机制研究现状:西方饮食模式与微生物群——叙述性综述。
Nutrients. 2022 Jun 17;14(12):2520. doi: 10.3390/nu14122520.
4
Discovery of bioactive microbial gene products in inflammatory bowel disease.在炎症性肠病中发现具有生物活性的微生物基因产物。
Nature. 2022 Jun;606(7915):754-760. doi: 10.1038/s41586-022-04648-7. Epub 2022 May 25.
5
Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets.炎症性肠病中的生态失调:致病作用和潜在治疗靶点。
Int J Mol Sci. 2022 Mar 23;23(7):3464. doi: 10.3390/ijms23073464.
6
Interleukin-6 absence triggers intestinal microbiota dysbiosis and mucosal immunity in mice.白细胞介素-6缺失引发小鼠肠道微生物群失调和黏膜免疫。
Cytokine. 2022 May;153:155841. doi: 10.1016/j.cyto.2022.155841. Epub 2022 Mar 8.
7
IBD-Associated Atg16L1T300A Polymorphism Regulates Commensal Microbiota of the Intestine.IBD 相关 Atg16L1T300A 多态性调节肠道共生菌群。
Front Immunol. 2022 Jan 27;12:772189. doi: 10.3389/fimmu.2021.772189. eCollection 2021.
8
Microbial pathogenesis in inflammatory bowel diseases.炎症性肠病中的微生物发病机制。
Microb Pathog. 2022 Feb;163:105383. doi: 10.1016/j.micpath.2021.105383. Epub 2021 Dec 30.
9
Mucins Dynamics in Physiological and Pathological Conditions.黏液素在生理和病理条件下的动态变化。
Int J Mol Sci. 2021 Dec 20;22(24):13642. doi: 10.3390/ijms222413642.
10
Potential of human helminth therapy for resolution of inflammatory bowel disease: The future ahead.人类蠕虫疗法治疗炎症性肠病的潜力:未来可期。
Exp Parasitol. 2022 Jan;232:108189. doi: 10.1016/j.exppara.2021.108189. Epub 2021 Nov 27.